Skip to main content
. 2021 May 10;39(10):2015–2021. doi: 10.1097/HJH.0000000000002891

TABLE 2.

Rates of specific cause-related comorbidities in hospitalized patients with secondary hypertension in China from 2013 to 2016

2013 2014 2015 2016 P for trend
Renal parenchymal disease [n (%)] 42 812 (58.89) 60 106 (59.58) 62 841 (56.77) 62 129 (52.59) <0.001
Renal vascular disease [n (%)] 2053 (2.82) 2274 (2.25) 2991 (2.70) 3388 (2.86) <0.001
Endocrine hypertension [n (%)] 5276 (7.25) 6823 (6.76) 8147 (7.36) 9757 (8.25) <0.001
 Cushing's syndrome [n (%)] 771 (1.06) 995 (0.98) 1172 (1.05) 1349 (1.14) 0.012
 Primary aldosteronism [n (%)] 3991 (5.49) 5148 (5.10) 6293 (5.68) 7564 (6.40) <0.001
 Pheochromocytoma [n (%)] 444 (0.61) 660 (0.65) 659 (0.59) 790 (0.66) 0.313
Diseases of aorta [n (%)] 739 (1.01) 1124 (1.11) 1401 (1.26) 1798 (1.52) <0.001
Obstructive sleep apnea syndrome [n (%)] 17 732 (24.39) 25 835 (25.61) 30 467 (27.52) 35 421 (29.98) <0.001